Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2024

Apr 9, 2024

30870_dirs_2024-04-09_c493c543-37ee-46dc-aed2-796c8f5f0363.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2024-04-09

Reporting Person: Malik Fady Ibraham (EVP Research & Development)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-04-09 Common Stock M 28605 $6.67 Acquired 171172 Direct
2024-04-09 Common Stock S 28605 $74.31 Disposed 142567 Direct
2024-04-09 Common Stock S 4000 $74.32 Disposed 138567 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-04-09 Non-Qualified Stock Option (Right to Buy) $6.67 M 28605 Disposed 2026-02-23 Common Stock (28605) Direct